Edward W. Withrow III - 31 Dec 2021 Form 5 Insider Report for PARALLAX HEALTH SCIENCES, INC.

Role: 10%+ Owner
Signature: EDWARD W. WITHROW III
Issuer symbol: N/A
Transactions as of: 31 Dec 2021
Net transactions value: +$99,932
Form type: 5
Filing time: 17 Mar 2022, 17:15:39 UTC
Previous filing: 04 Mar 2022
Next filing: 17 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRLX	PREFERRED STOCK (SERIES A)	Other	$99,932	+36,339	+10%	$2.75	399,732	30 Sep 2011	By Huntington Chase Financial Group	F1
transaction	PRLX	PREFERRED STOCK (SERIES A)	Other	$0	+396,339	+99%	$0.000000	796,071	06 Nov 2021	By Huntington Chase Financial Group	F2
transaction	PRLX	PREFERRED STOCK (SERIES A)	Other	$0	-796,071	-100%	$0.000000^*	0	06 Nov 2021	By Huntington Chase Financial Group	F3
transaction	PRLX	COMMON STOCK	Other	$0	+15,921,420	+28%	$0.000000	72,430,792	06 Nov 2021	By Huntington Chase LLC	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRLX	STOCK OPTION	Disposed to Issuer	$0	-3,000,000	-75%	$0.000000	1,000,000	31 Mar 2021	COMMON STOCK	3,000,000	$0.2500	By Huntington Chase LLC	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Additional Series A Preferred shares acquired; not included in previous Form 5 for the year 12/31/2012. Total Series A Preferred shares held at 12/31/12 = 399,732.
F2	Cumulative dividends in kind on Series A Preferred Stock.
F3	Conversion of preferred stock into common stock at a ratio of 20 shares of common stock for each share of preferred stock.
F4	Unvested stock options canceled upon resignation of Reporting Person.